21 Apr 2003
UCB: First quarter Zyrtec sales in the US.
Read More
31 Mar 2003
Data analysis shows Keppra® reduced partial seizures in nearly 80 percent of elderly patients in a community-based trial.
Read More
14 Mar 2003
UCB Group : confirmation of an increase in ordinary profits of 7%.
Read More
25 Feb 2003
Celltech Group PLC (CCH) - Offer for Oxford GlycoScience
Read More
5 Feb 2003
The UCB Group in 2002: Preliminary Unaudited Profits. Record Ordinary Profits before Tax of € 494 million, an increase of 7%
Read More
30 Jan 2003
UCB closes on its acquisition of Solutia's Resins, Additives and Adhesives businesses
Read More
